논문KCI 등재
Unveiling GULP1 as a hepatocyte-specific role for re currence: Editorial on “GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma”
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
관련 논문AI추천
GULP1, a multifaceted diagnostic biomarker and po tential therapeutic target in hepatocellular carcinoma: Editorial on “GULP1 as a novel diagnostic and predic tive biomarker in hepatocellular carcinoma”John Wurpel, Lu-Qi Cao, Yuhao Xie, Zhe-Sheng Chen대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호Letter to the editor on “GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma”Juan Yang, Sheng Zheng, Xinyi Li대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호GULP1: New hope for hepatocellular carcinoma: Reply to correspondence on “GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma”John Wurpel, Lu-Qi Cao, Yuhao Xie, Zhe-Sheng Chen대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호Correspondence to editorial on “GULP1 as a novel di agnostic and predictive biomarker in hepatocellular carcinoma”Hyung Seok Kim, Jae Youn Cheong, Jung Woo Eun, Soon Sun Kim대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호Correspondence to letter to the editor on “GULP1 as a novel diagnostic and predictive biomarker in hepato cellular carcinoma”Hyung Seok Kim, Jae Youn Cheong, Jung Woo Eun, Soon Sun Kim대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinomaGeum Ok Baek, Hyo Jung Cho, Hyung Seok Kim, Jae Youn Cheong, Jee-Yeong Jeong, Jestlin Tianthing Ng, Ji Eun Han, Ji Yi Choi, Jung Hwan Yoon, Jung Woo Eun, Minji Kang, Moon Gyeong Yoon, Se Ha Jang, Soon Sun Kim, Su Bin Lim, Suk Woo Nam, Won Park, Yunjin Go대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제3호
이 간행물의 다른 논문 (76건)
2025 KASL clinical practice guidelines for management of hepatitis CEun Sun Jang, Eun Ju Cho, Chang Hun Lee, Do Seon Song, Nae-Yun Heo, Jae Yoon Jeong, Jung Gil Park, Jae Seung Lee, Jae Hyun Yoon, Seul Ki Han, Young Kul Jungpp. 1-52Critical considerations in evaluating the therapeutic potential of HK-660S for primary sclerosing cholangi tis: Letter to the editor on “Safety and efficacy of HK 660S in patients with primary sclerosing cholangitis: a randomized double-blind phase 2a trial”Yizi He, Haifeng He, Qi Liang, Yongzhi Xiepp. 1-3Letter to the editor on “Current burden of steatotic liv er disease and fibrosis among adults in the United States, 2017–2023”Sisi Yang, Zhenxuan Mapp. 4-6Letter to the editor on “Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcino ma: a nationwide cohort study”Xiaodi Yang, Zhongqing Qian, Qiong Wang, Fuliang Chen, Xiaojing Wang, Deyan Chenpp. 7-9Letter to the editor on “GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma”Juan Yang, Xinyi Li, Sheng Zhengpp. 10-12